BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 7498193)

  • 1. Natural history of cardiac involvement in myotonic dystrophy type 1 - Emphasis on the need for lifelong follow-up.
    Petri H; Mohammad BJY; Kristensen AT; Thune JJ; Vissing J; Køber L; Witting N; Bundgaard H; Christensen AH
    Int J Cardiol; 2024 Jul; 406():132070. PubMed ID: 38643802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value.
    Russo V; Capolongo A; Bottino R; Carbone A; Palladino A; Liccardo B; Nigro G; Marchel M; Golino P; D'Andrea A
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.
    Alexandridis GM; Pagourelias ED; Fragakis N; Kyriazi M; Vargiami E; Zafeiriou D; Vassilikos VP
    Heart Fail Rev; 2022 Nov; 27(6):2045-2058. PubMed ID: 35857244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Pathology in Myotonic Dystrophy Type 1.
    Mahadevan MS; Yadava RS; Mandal M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies.
    Lamacie MM; Warman-Chardon J; Crean AM; Florian A; Wahbi K
    J Neuromuscul Dis; 2019; 6(4):389-399. PubMed ID: 31561382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.
    Hamilton MJ; Robb Y; Cumming S; Gregory H; Duncan A; Rahman M; McKeown A; McWilliam C; Dean J; Wilcox A; Farrugia ME; Cooper A; McGhie J; Adam B; Petty R; ; Longman C; Findlay I; Japp A; Monckton DG; Denvir MA
    PLoS One; 2017; 12(3):e0174166. PubMed ID: 28323905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle wasting in myotonic dystrophies: a model of premature aging.
    Mateos-Aierdi AJ; Goicoechea M; Aiastui A; Fernández-Torrón R; Garcia-Puga M; Matheu A; López de Munain A
    Front Aging Neurosci; 2015; 7():125. PubMed ID: 26217220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Petri H; Ahtarovski KA; Vejlstrup N; Vissing J; Witting N; Køber L; Bundgaard H
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):59. PubMed ID: 25086734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural myocardial involvement in adult patients with type 1 myotonic dystrophy.
    Dhand UK; Raja F; Aggarwal K
    Neurol Int; 2013 Feb; 5(1):e5. PubMed ID: 23717784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Hermans MC; Faber CG; Bekkers SC; de Die-Smulders CE; Gerrits MM; Merkies IS; Snoep G; Pinto YM; Schalla S
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):48. PubMed ID: 22827830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.
    Turkbey EB; Gai N; Lima JA; van der Geest RJ; Wagner KR; Tomaselli GF; Bluemke DA; Nazarian S
    Heart Rhythm; 2012 Oct; 9(10):1691-7. PubMed ID: 22710483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of biventricular functions with tissue Doppler imaging in patients with myotonic dystrophy.
    Ozyigit T; Ozben B; Oflaz H; Serdaroglu P
    Clin Cardiol; 2010 Mar; 33(3):126-31. PubMed ID: 20235214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.
    Breton R; Mathieu J
    Can J Cardiol; 2009 Feb; 25(2):e23-7. PubMed ID: 19214296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECG abnormalities in myopathies, coronary heart disease and controls.
    Finsterer J; Stöllberger C; Köcher K; Mamoli B
    Herz; 1997 Oct; 22(5):277-82. PubMed ID: 9360915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac involvement in patients with myotonic dystrophy, Becker's muscular dystrophy and mitochondrial myopathy.
    Finsterer J; Stöllberger C; Keller H; Slany J; Mamoli B
    Herz; 1997 Apr; 22(2):96-103. PubMed ID: 9134443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature.
    Meola G; Sansone V
    Ital J Neurol Sci; 1996 Oct; 17(5):347-53. PubMed ID: 8933228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging.
    De Ambroggi L; Raisaro A; Marchianó V; Radice S; Meola G
    Eur Heart J; 1995 Jul; 16(7):1007-10. PubMed ID: 7498193
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.